BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6114827)

  • 1. Thioredoxin-dependent sulfoxide reduction by rat renal cytosol.
    Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
    Drug Metab Dispos; 1981; 9(4):307-10. PubMed ID: 6114827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfoxide reduction. In vitro reduction of sulindac by rat hepatic cytosolic enzymes.
    Ratnayake JH; Hanna PE; Anders MW; Duggan DE
    Drug Metab Dispos; 1981; 9(2):85-7. PubMed ID: 6113122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of thioredoxin in sulfoxide reduction by mammalian tissues.
    Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
    Biochem Biophys Res Commun; 1980 Dec; 97(3):846-51. PubMed ID: 7470152
    [No Abstract]   [Full Text] [Related]  

  • 4. S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione.
    Jung CH; Thomas JA
    Arch Biochem Biophys; 1996 Nov; 335(1):61-72. PubMed ID: 8914835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.
    Duggan DE; Hooke KF; Hwang SS
    Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thioredoxin system from Streptomyces coelicolor.
    Stefanková P; Perecko D; Barák I; Kollárová M
    J Basic Microbiol; 2006; 46(1):47-55. PubMed ID: 16463318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal metabolism of sulindac: functional implications.
    Miller MJ; Bednar MM; McGiff JC
    J Pharmacol Exp Ther; 1984 Nov; 231(2):449-56. PubMed ID: 6436473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat.
    Swanson BN; Mojaverian P; Boppana VK
    J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism in vitro of sulindac. Sulfoxide-reducing enzyme systems in guinea pig liver.
    Kitamura S; Tatsumi K; Yoshimura H
    J Pharmacobiodyn; 1980 Jun; 3(6):290-8. PubMed ID: 6775073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linked thioredoxin-glutathione systems in platyhelminths.
    Salinas G; Selkirk ME; Chalar C; Maizels RM; Fernández C
    Trends Parasitol; 2004 Jul; 20(7):340-6. PubMed ID: 15193566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the biologically active form of sulindac.
    Duggan DE; Hooke KF; Risley EA; Shen TY; Arman CG
    J Pharmacol Exp Ther; 1977 Apr; 201(1):8-13. PubMed ID: 850147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone.
    Kitamura S; Tatsumi K
    Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General acid/base catalysis in the active site of Escherichia coli thioredoxin.
    Chivers PT; Raines RT
    Biochemistry; 1997 Dec; 36(50):15810-6. PubMed ID: 9398311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl sulfoxide inhibits bioactivation of sulindac.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-dependent oxidation of thioredoxin during cellular growth initiation.
    Gitler C; Zarmi B; Kalef E; Meller R; Zor U; Goldman R
    Biochem Biophys Res Commun; 2002 Jan; 290(2):624-8. PubMed ID: 11785944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
    Wang PF; Marcinkeviciene J; Williams CH; Blanchard JS
    Biochemistry; 1998 Nov; 37(46):16378-89. PubMed ID: 9819230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.
    Duggan DE
    Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dimethyl sulfoxide on sulindac disposition in rats.
    Swanson BN; Mojaverian P; Boppana VK; Dudash MR
    Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase.
    Holmgren A; Lyckeborg C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5149-52. PubMed ID: 6933551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms.
    Biaglow JE; Donahue J; Tuttle S; Held K; Chrestensen C; Mieyal J
    Anal Biochem; 2000 May; 281(1):77-86. PubMed ID: 10847613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.